866-997-4948(US-Canada Toll Free)

United States Hospital-acquired Disease Testing Market Report 2017

Published By :

QYResearch

Published Date : Feb 2017

Category :

Pharmaceutical

No. of Pages : 107 Pages

Notes:
Sales, means the sales volume of Hospital-acquired Disease Testing
Revenue, means the sales value of Hospital-acquired Disease Testing

This report studies sales (consumption) of Hospital-acquired Disease Testing in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering
Abbott Laboratories
Becton and Dickenson
BioMerieux
Roche Diagnostics
Akers Biosciences
Alere
Beckman Coulter/Danaher
Cantel Medical
Cepheid
Diatherix Laboratories
Eiken Chemical
Enzo Biochem
Fujirebio/Innogenetics
Gen-Probe
Humor Diagnostica
Life Technologies
Meridian Bioscience
Nordion
QIAGEN

Market Segment by States, covering
California
Texas
New York
Florida
Illinois
Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into
Type I
Type II
Split by applications, this report focuses on sales, market share and growth rate of Hospital-acquired Disease Testing in each application, can be divided into
Application 1
Application 2

Table of Contents

United States Hospital-acquired Disease Testing Market Report 2017
1 Hospital-acquired Disease Testing Overview
1.1 Product Overview and Scope of Hospital-acquired Disease Testing
1.2 Classification of Hospital-acquired Disease Testing
1.2.1 Type I
1.2.2 Type II
1.3 Application of Hospital-acquired Disease Testing
1.3.1 Application 1
1.3.2 Application 2
1.4 United States Market Size Sales (Volume) and Revenue (Value) of Hospital-acquired Disease Testing (2012-2022)
1.4.1 United States Hospital-acquired Disease Testing Sales and Growth Rate (2012-2022)
1.4.2 United States Hospital-acquired Disease Testing Revenue and Growth Rate (2012-2022)

2 United States Hospital-acquired Disease Testing Competition by Manufacturers
2.1 United States Hospital-acquired Disease Testing Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Hospital-acquired Disease Testing Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Hospital-acquired Disease Testing Average Price by Manufactures (2015 and 2016)
2.4 Hospital-acquired Disease Testing Market Competitive Situation and Trends
2.4.1 Hospital-acquired Disease Testing Market Concentration Rate
2.4.2 Hospital-acquired Disease Testing Market Share of Top 3 and Top 5 Manufacturers
2.4.3 Mergers & Acquisitions, Expansion

3 United States Hospital-acquired Disease Testing Sales (Volume) and Revenue (Value) by States (2012-2017)
3.1 United States Hospital-acquired Disease Testing Sales and Market Share by States (2012-2017)
3.2 United States Hospital-acquired Disease Testing Revenue and Market Share by States (2012-2017)
3.3 United States Hospital-acquired Disease Testing Price by States (2012-2017)

4 United States Hospital-acquired Disease Testing Sales (Volume) and Revenue (Value) by Type (2012-2017)
4.1 United States Hospital-acquired Disease Testing Sales and Market Share by Type (2012-2017)
4.2 United States Hospital-acquired Disease Testing Revenue and Market Share by Type (2012-2017)
4.3 United States Hospital-acquired Disease Testing Price by Type (2012-2017)
4.4 United States Hospital-acquired Disease Testing Sales Growth Rate by Type (2012-2017)

5 United States Hospital-acquired Disease Testing Sales (Volume) by Application (2012-2017)
5.1 United States Hospital-acquired Disease Testing Sales and Market Share by Application (2012-2017)
5.2 United States Hospital-acquired Disease Testing Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 United States Hospital-acquired Disease Testing Manufacturers Profiles/Analysis
6.1 Abbott Laboratories
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Hospital-acquired Disease Testing Product Type, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Abbott Laboratories Hospital-acquired Disease Testing Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Becton and Dickenson
6.2.2 Hospital-acquired Disease Testing Product Type, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Becton and Dickenson Hospital-acquired Disease Testing Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 BioMerieux
6.3.2 Hospital-acquired Disease Testing Product Type, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 BioMerieux Hospital-acquired Disease Testing Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 Roche Diagnostics
6.4.2 Hospital-acquired Disease Testing Product Type, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Roche Diagnostics Hospital-acquired Disease Testing Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Akers Biosciences
6.5.2 Hospital-acquired Disease Testing Product Type, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Akers Biosciences Hospital-acquired Disease Testing Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 Alere
6.6.2 Hospital-acquired Disease Testing Product Type, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Alere Hospital-acquired Disease Testing Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 Beckman Coulter/Danaher
6.7.2 Hospital-acquired Disease Testing Product Type, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Beckman Coulter/Danaher Hospital-acquired Disease Testing Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 Cantel Medical
6.8.2 Hospital-acquired Disease Testing Product Type, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Cantel Medical Hospital-acquired Disease Testing Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview
6.9 Cepheid
6.9.2 Hospital-acquired Disease Testing Product Type, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Cepheid Hospital-acquired Disease Testing Sales, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Main Business/Business Overview
6.10 Diatherix Laboratories
6.10.2 Hospital-acquired Disease Testing Product Type, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 Diatherix Laboratories Hospital-acquired Disease Testing Sales, Revenue, Price and Gross Margin (2012-2017)
6.10.4 Main Business/Business Overview
6.11 Eiken Chemical
6.12 Enzo Biochem
6.13 Fujirebio/Innogenetics
6.14 Gen-Probe
6.15 Humor Diagnostica
6.16 Life Technologies
6.17 Meridian Bioscience
6.18 Nordion
6.19 QIAGEN

7 Hospital-acquired Disease Testing Manufacturing Cost Analysis
7.1 Hospital-acquired Disease Testing Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Hospital-acquired Disease Testing

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Hospital-acquired Disease Testing Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Hospital-acquired Disease Testing Major Manufacturers in 2015
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 United States Hospital-acquired Disease Testing Market Forecast (2017-2022)
11.1 United States Hospital-acquired Disease Testing Sales, Revenue Forecast (2017-2022)
11.2 United States Hospital-acquired Disease Testing Sales Forecast by Type (2017-2022)
11.3 United States Hospital-acquired Disease Testing Sales Forecast by Application (2017-2022)
11.4 Hospital-acquired Disease Testing Price Forecast (2017-2022)

12 Research Findings and Conclusion

13 Appendix
Methodology
Analyst Introduction
Data Source

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *